SCOPOLAMINE MARKET ANALYSIS

Scopolamine Market Size and Trends

Global scopolamine market is estimated to be valued at USD 485.1 Mn in 2024 and is expected to reach USD 739.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

To learn more about this report, request sample copy

Rising incidence of motion sickness, specialty drug innovation, and technological advancements can drive the market growth. Moreover, factors such as easy availability and low cost of generic medicines for motion sickness can also drive the scopolamine market growth during the forecast period. However, side effects associated with scopolamine drugs such as blurred vision, dry mouth and others can hamper the market growth.

Growing treatment trials on scopolamine

 Scopolamine is used for treating various medical conditions.  Several clinical trials investigating the effectiveness of scopolamine patches and gels for nausea, vomiting, motion sickness and other issues have provided promising results. This has generated significant interest in pharmaceutical companies to further research and develop scopolamine-based products. For instance, in 2021, according to a trial conducted by the National Institutes of Health, scopolamine patches were effective in reducing chemotherapy-induced nausea and vomiting in 80% of cancer patients.

In 2020, according to a study published by American Journal of Medicine, scopolamine nasal spray reduced symptoms in 70% of individuals experiencing dizziness. For instance, in April 2021, according to an article published by Jama Network, there was decline in surgical procedures nationwide, a trend that began during the initial surge of the COVID-19 pandemic and persisted thereafter. This reduction directly affected demand for scopolamine-based formulations that is used to prevent nausea and vomiting following anesthesia, opioid pain medications, and surgeries.  For instance, in January 2022, according to a report published by Euractiv, approximately 400,000 surgeries were postponed during the pandemic, leading to a significant increase in patient waitlists.

Motion sickness as a growing health issue

Rising incidence of motion sickness globally can drive the market growth. Motion sickness refers to a set of symptoms like nausea, vomiting and dizziness that is experienced when travelling in boats, trains, cars or airplanes. It is triggered due to discrepancies between visual motion cues and signals coming from different balance mechanisms like the vestibular system in the inner ear. Long distance travels have become very common nowadays due to improving transportation infrastructure and increasing mobility. However, even short trips induce motion sickness in many people. Children and the elderly are especially vulnerable to motion sickness. Prolonged bouts of motion sickness can cause discomfort, anxiety and even lead to misses from school or work. Scopolamine transdermal patches are a popular preventive treatment option for this health issue due to their non-invasive nature and longer duration of action. Increasing awareness about motion sickness and availability of effective over-the-counter remedies like scopolamine can boost demand for scopolamine.